---
title: "Pharscin Pharma obtained the drug registration certificate for Crizotinib capsules"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261847712.md"
description: "Pharscin Pharma has obtained the drug registration certificate for Crizotinib capsules issued by the National Medical Products Administration. This drug was launched in the Chinese market in 2013 and was included in the medical insurance system in 2018, with over ten years of clinical application experience, primarily used for the treatment of patients with advanced non-small cell lung cancer who are ALK-positive and ROS1-positive"
datetime: "2025-10-20T09:43:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261847712.md)
  - [en](https://longbridge.com/en/news/261847712.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261847712.md)
---

# Pharscin Pharma obtained the drug registration certificate for Crizotinib capsules

According to the news from Zhitong Finance APP, Pharscin Pharma (002907.SZ) announced that the company has received the "Drug Registration Certificate" for its product Crizotinib Capsules approved and issued by the National Medical Products Administration. Crizotinib Capsules were launched in the Chinese market in 2013, included in medical insurance in 2018, and have accumulated over ten years of clinical application experience. This drug is primarily used in clinical settings for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are positive for anaplastic lymphoma kinase (ALK), as well as patients with advanced non-small cell lung cancer (NSCLC) who are positive for ROS1

### Related Stocks

- [002907.CN](https://longbridge.com/en/quote/002907.CN.md)

## Related News & Research

- [Cramer reiterates debt-coverage rule amid high-rate pressures](https://longbridge.com/en/news/287048552.md)
- [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md)
- [Ganfeng Lithium starts small-scale production of 500 Wh/kg solid-state batteries](https://longbridge.com/en/news/287152551.md)
- [RUBBER-Japan futures fall on rising supply prospects, weak demand](https://longbridge.com/en/news/287175409.md)
- [AI|China’s Ganfeng secures orders amid surge in demand for energy storage, AI boom](https://longbridge.com/en/news/286895092.md)